Literature DB >> 21265881

Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease.

Shenglin Liu1, Wang Shi, Guolin Li, Bo Jin, Yaqin Chen, Hui Hu, Li Liu, Fuxia Xie, Keke Chen, Dazhong Yin.   

Abstract

BACKGROUND AND AIM: Oxidative stress plays a critical role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, there is still no large cohort study to explore the direct risk role of oxidative stress for NAFLD. This study is to test the hypothesis that elevated oxidative stress is a direct risk factor for the pathogenesis of NAFLD under controlling the potential effects of covariates.
METHODS: The levels of serum cholesterol, serum triglyceride, fasting plasma glucose and plasma reactive carbonyl species (RCS) were measured from 1204 Chinese Han adults, and the questionnaire and physical examination were administered to those with known and suspected risk factors for NAFLD.
RESULTS: Statistically significant high levels of blood pressure, fasting plasma glucose, serum cholesterol and triglyceride, body mass index, serum alanine aminotransferase and aspartate aminotransferase, and plasma RCS were observed in NAFLD subjects compared to healthy subjects (P < 0.01). Multivariate-adjusted odds ratio illustrated that, compared with the lowest quartile of plasma RCS levels, the highest quartile subjects had a 132% increase in the risk of developing NAFLD. Further results from multi-interaction analysis demonstrated that the underlying mechanism of the risk of NAFLD by unhealthy physical conditions and lifestyles might be, at least in part, through the oxidative stress.
CONCLUSIONS: Our findings provide credible evidence from a large population that oxidative stress, as indicated by plasma RCS levels, may be a direct risk factor for developing NAFLD.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21265881     DOI: 10.1111/j.1440-1746.2011.06672.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Association between age-related decline of kidney function and plasma malondialdehyde.

Authors:  Guolin Li; Yaqin Chen; Hui Hu; Li Liu; Xiaofei Hu; Jun Wang; Wang Shi; Dazhong Yin
Journal:  Rejuvenation Res       Date:  2012-04-24       Impact factor: 4.663

2.  Plasma components affect accuracy of circulating cancer-related microRNA quantitation.

Authors:  Dong-Ja Kim; Sarah Linnstaedt; Jaime Palma; Joon Cheol Park; Evangelos Ntrivalas; Joanne Y H Kwak-Kim; Alice Gilman-Sachs; Kenneth Beaman; Michelle L Hastings; Jeffrey N Martin; Dominik M Duelli
Journal:  J Mol Diagn       Date:  2011-11-30       Impact factor: 5.568

Review 3.  Biomarkers in nonalcoholic fatty liver disease.

Authors:  Manuela G Neuman; Lawrence B Cohen; Radu M Nanau
Journal:  Can J Gastroenterol Hepatol       Date:  2014-12

Review 4.  The Effects of Physical Exercise on Fatty Liver Disease.

Authors:  Dirk J van der Windt; Vikas Sud; Hongji Zhang; Allan Tsung; Hai Huang
Journal:  Gene Expr       Date:  2017-12-06

5.  Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population.

Authors:  Guolin Li; Wang Shi; Hui Hug; Yaqin Chen; Li Liu; Dazhong Yin
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

6.  Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease.

Authors:  Xiaobing Dou; Songtao Li; Linfeng Hu; Lei Ding; Yue Ma; Wang Ma; Hui Chai; Zhenyuan Song
Journal:  Exp Mol Med       Date:  2018-04-06       Impact factor: 8.718

Review 7.  Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk.

Authors:  Nuria Barbarroja; Miriam Ruiz-Ponce; Laura Cuesta-López; Carlos Pérez-Sánchez; Chary López-Pedrera; Iván Arias-de la Rosa; Eduardo Collantes-Estévez
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

8.  Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease.

Authors:  Chih-Hung Guo; Pei-Chung Chen; Wang-Sheng Ko
Journal:  Int J Med Sci       Date:  2013-04-17       Impact factor: 3.738

9.  Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.

Authors:  Xu Chen; Hongliang Xue; Wanjun Fang; Ke Chen; Shen Chen; Wenqi Yang; Tianran Shen; Xuechen Chen; Peiwen Zhang; Wenhua Ling
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.